Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.
about
The immunoreactive patient: Rejection and autoimmune diseaseA prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center reportEfficacy of mycofenolate mofetil for steroid-resistant acute rejection after living donor liver transplantation.Prophylaxis and treatment of gastrointestinal complications following transplantation.Liver transplantation in the UK.Gastrointestinal pathology in transplant patients.Iatrogenic pathology of the intestines.Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients.Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient.A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.Short-term treatment with mycophenolic acid increases bile flow in continuously perfused and cold-preserved rat livers and does not affect hepatic ischemia-reperfusion injury.Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction.Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
P2860
Q26860876-F59C1FFB-6F39-4280-80B1-9D1A56ABE84CQ28360654-A4923963-4836-48D7-A86A-455A2BDD6AE7Q33867029-6B946E94-BA5B-484F-9EC3-C466C08627B7Q34485493-081AF736-4ED7-4DE7-96A0-9B39376FA93FQ34512132-02FBB591-2B40-451B-8A3B-7A8A4C34A2D9Q38246641-62B5E72B-96E1-492F-A517-7D412C758D8AQ38339456-07A88527-F6D7-4114-8C31-08134D7ED655Q41241023-A705DBE9-06BD-4788-88A2-CB52E8C4241FQ43037856-29E502DC-3DE0-4300-B7BF-78770464A92AQ43548983-E906F937-1229-48B3-9E4A-D9BA8DF7B265Q43604925-13074A6E-A2B5-4807-8F40-CA99AA56FEBFQ44033831-9724DA27-CB08-42E1-9EBD-B2A9C8756227Q44903389-639B87FD-46F0-4969-B85E-639E14779955Q45057607-2E65CE4E-F3BC-4D9C-81C1-1C7215BB3339Q45289872-64EFBF4A-1D6B-4232-8645-3D90FCA98619Q57791759-BAAE93FA-36B6-4F4F-BA47-064E8805D1CE
P2860
Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Four-year follow-up of mycophe ...... in liver allograft recipients.
@ast
Four-year follow-up of mycophe ...... in liver allograft recipients.
@en
Four-year follow-up of mycophe ...... in liver allograft recipients.
@nl
type
label
Four-year follow-up of mycophe ...... in liver allograft recipients.
@ast
Four-year follow-up of mycophe ...... in liver allograft recipients.
@en
Four-year follow-up of mycophe ...... in liver allograft recipients.
@nl
prefLabel
Four-year follow-up of mycophe ...... in liver allograft recipients.
@ast
Four-year follow-up of mycophe ...... in liver allograft recipients.
@en
Four-year follow-up of mycophe ...... in liver allograft recipients.
@nl
P2093
P1433
P1476
Four-year follow-up of mycophe ...... in liver allograft recipients
@en
P2093
P304
P356
10.1097/00007890-199903150-00011
P50
P577
1999-03-01T00:00:00Z